Paul L. Berns - 27 Dec 2024 Form 4 Insider Report for Neumora Therapeutics, Inc. (NMRA)

Role
Director
Signature
/s/ Joshua Pinto, as Attorney-in-Fact for Paul L. Berns
Issuer symbol
NMRA
Transactions as of
27 Dec 2024
Net transactions value
$0
Form type
4
Filing time
27 Dec 2024, 17:01:21 UTC
Previous filing
21 Jun 2024
Next filing
30 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NMRA Common Stock Gift $0 -133,097 -1.7% $0.000000 7,685,069 27 Dec 2024 Direct F1
transaction NMRA Common Stock Gift $0 -133,097 -1.7% $0.000000 7,551,972 27 Dec 2024 Direct F1
transaction NMRA Common Stock Gift $0 -133,097 -1.8% $0.000000 7,418,875 27 Dec 2024 Direct F1
holding NMRA Common Stock 133,097 27 Dec 2024 See footnote F2
holding NMRA Common Stock 133,097 27 Dec 2024 See footnote F3
holding NMRA Common Stock 133,097 27 Dec 2024 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 27, 2024, the Reporting Person transferred, for no consideration, 133,097 shares of Common Stock to each of LULU TRUST OF 2024 FBO AB, LULU TRUST OF 2024 FBO OB, and LULU TRUST OF 2024 FBO HB, of which members of the Reporting Person's immediate family are the sole beneficiaries.
F2 Held by LULU TRUST OF 2024 FBO AB.
F3 Held by LULU TRUST OF 2024 FBO OB.
F4 Held by LULU TRUST OF 2024 FBO HB.